News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

National Institute of Standards and Technology Awards $2 Million to 20/20 GeneSystems, Inc. for Innovative Tumor Profiling Technology


10/5/2007 10:30:50 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--20/20 GeneSystems, Inc. (“20/20”) announced today that the National Institute of Standards and Technology (NIST) Advanced Technology Program (ATP) has awarded $1.9 million to 20/20 GeneSystems for the development of a technique known as Layered Expression Scanning-Diagnostic (LES-Dx) for tumor profiling to better predict whether cancer patients will respond to certain “personalized” chemotherapy drugs.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES